Related Experiment Video
Updated: May 3, 2026

Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
IL-4, JAK-STAT signaling, and pain
Melanie Busch-Dienstfertig1, Sara González-Rodríguez1
1Department of Anesthesiology and Critical Care Medicine; Charité Campus Benjamin Franklin; Freie Universität Berlin; Berlin, Germany.
Abstract:
During inflammation, several mediators directly or indirectly induce pain including pro-inflammatory cytokines and there is evidence that the JAK-STAT pathway is involved in the formation of pronociceptive cytokines. The same pathway, however, is also of importance for anti-inflammatory cytokines such as IL-4 to counteract the inflammatory reaction and-as it seems based on the current literature-nociceptive symptoms. Current therapeutic approaches targeting molecules of the JAK-STAT signaling cascade are auspicious but as this review demonstrates, more experimental and clinical studies are required to decipher the specific contribution of this pathway in the modulation of pain.
Insights
The JAK-STAT pathway influences pain by mediating both pro-inflammatory and anti-inflammatory cytokines. Further research is needed to understand its specific role in pain modulation for therapeutic development.
Area of Science:
- Immunology
- Neuroscience
- Pharmacology
Background:
- Inflammation involves mediators like pro-inflammatory cytokines that induce pain.
- The Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway is implicated in cytokine production.
- The JAK-STAT pathway also plays a role in anti-inflammatory responses, potentially counteracting pain.
Purpose of the Study:
- To review the dual role of the JAK-STAT pathway in pain modulation.
- To highlight the involvement of JAK-STAT in both pain-inducing and pain-alleviating cytokine signaling.
- To identify the need for further research into JAK-STAT's specific contribution to pain.
Main Methods:
- Literature review of experimental and clinical studies.
- Analysis of the JAK-STAT signaling cascade in the context of inflammation and pain.
- Synthesis of current evidence on JAK-STAT's role in pronociceptive and anti-nociceptive cytokine formation.
Main Results:
- The JAK-STAT pathway is involved in the generation of pro-inflammatory cytokines that contribute to pain.
- The pathway also mediates the action of anti-inflammatory cytokines, such as IL-4, which can reduce inflammatory pain.
- Evidence suggests a complex, dual role for JAK-STAT in pain perception.
Conclusions:
- The JAK-STAT pathway is a significant modulator of pain through its influence on cytokine balance.
- Targeting JAK-STAT signaling for pain management is a promising therapeutic strategy.
- More research is essential to fully elucidate the specific mechanisms and therapeutic potential of JAK-STAT modulation in pain.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Nociception

